Changes in Chemokines and Chemokine Receptors Expression in a Mouse Model of Alzheimer's Disease
NAGIOS: RODERIC FUNCIONANDO

Changes in Chemokines and Chemokine Receptors Expression in a Mouse Model of Alzheimer's Disease

DSpace Repository

Changes in Chemokines and Chemokine Receptors Expression in a Mouse Model of Alzheimer's Disease

Show simple item record

dc.contributor.author Jordá Vallés, Adrián
dc.contributor.author Cauli, Omar
dc.contributor.author Santonja, José M
dc.contributor.author Aldasoro Celaya, Martín
dc.contributor.author Aldasoro, Constanza
dc.contributor.author Obrador Plá, Elena
dc.contributor.author Vila Salinas, José María
dc.contributor.author Mauricio Aviñó, María Dolores
dc.contributor.author Iradi Casal, Antonio
dc.contributor.author Guerra Ojeda, Sol
dc.contributor.author Marchio, Patricia
dc.contributor.author Vallés Martí, Lilián Soraya
dc.date.accessioned 2020-04-21T08:51:46Z
dc.date.available 2020-04-21T08:51:46Z
dc.date.issued 2019
dc.identifier.uri https://hdl.handle.net/10550/73942
dc.description.abstract The amyloid precursor protein plus presenilin-1 (APP/PS1) mice are a frequently-used model for Alzheimer's disease studies (AD). However, the data relevant to which proteins are involved in inflammatory mechanism are not sufficiently well-studied using the AD mouse model. Using behavioral studies, quantitative RT-PCR and Western-blot techniques, significant findings were determined by the expression of proteins involved in inflammation comparing APP/PS1 and Wild type mice. Increased GFAP expression could be associated with the elevation in number of reactive astrocytes. IL-3 is involved in inflammation and ABDF1 intervenes normally in the transport across cell membranes and both were found up-regulated in APP/PS1 mice compared to Wild type mice. Furthermore, CCR5 expression was decreased and both CCL3 and CCL4 chemokines were highly expressed indicating a possible gliosis and probably an increase in chemotaxis from lymphocytes and T cell generation. We also noted for the first time, a CCR8 increase expression with diminution of its CCL1 chemokine, both normally involved in protection from bacterial infection and demyelination. Control of inflammatory proteins will be the next step in understanding the progression of AD and also in determining the mechanisms that can develop in this disease.
dc.language.iso cat
dc.relation.ispartof International Journal Of Biological Sciences, 2019, vol. 15, num. 2, p. 453-463
dc.rights.uri info:eu-repo/semantics/openAccess
dc.source Jordá Vallés, Adrián Cauli, Omar Santonja, José M Aldasoro Celaya, Martín Aldasoro, Constanza Obrador Plá, Elena Vila Salinas, José María Mauricio Aviñó, María Dolores Iradi Casal, Antonio Guerra Ojeda, Sol Marchio, Patricia Vallés Martí, Lilián Soraya 2019 Changes in Chemokines and Chemokine Receptors Expression in a Mouse Model of Alzheimer's Disease. Int J Biol Sci. 2019 Jan 1;15(2):453-463. doi: 10.7150/ijbs.26703. eCollection 2019. PMID: 30745834 International Journal Of Biological Sciences 15 2 453 463
dc.title Changes in Chemokines and Chemokine Receptors Expression in a Mouse Model of Alzheimer's Disease
dc.type info:eu-repo/semantics/article
dc.date.updated 2020-04-21T08:51:47Z
dc.identifier.doi https://doi.org/10.7150/ijbs.26703
dc.identifier.idgrec 131937

View       (751.4Kb)

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search

Browse

Statistics